Replies to post #381 on Cempra, Inc. (CEMP)

[Johnny_C]

I thought 100% this would be approved, my wife was 50 50 leaning towards approval.

But you cannot say this was just an FDA screwup, the Company CEO had alot to do with it. She repeatedly stated on calls this was totally safe and did not address the issues. I was on many calls, and if the FDA really had it in for Prabha why would they fastrack it.

At the very least they should have approved with warning and run a Phase 4 but my opinion doesn't count. Many of these small Bio's don't dot the i's and cross the t's. They should have known that on the safety side every trial is thrown into the mix, not just the indication they were trying to achieve.

On the bright side, the stock is at near all time lows and trading at cash. One year from now it may be a $40.00 stock. But I bet the FDA will continue to be a thorn if nothing else than to defend their previous ruling.

[Johnny_C]

Cemp has about 3.25 in cash and another 4 dollars in tax benefits at current tax rates. They must also have credits as well.